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S U M M A R Y
Invasive dematiaceous fungal sinusitis is an uncommon and aggressive disease in immunocompromised
individuals. We report a unique case of invasive Exserohilum sinusitis in a pregnant, immunocompro-
mised woman. After treating the woman with pregnancy-induced aplastic anemia and invasive
Exserohilum sinusitis and pulmonary disease, we performed a Medline/PubMed review of invasive
dematiaceous fungal sinonasal disease in immunocompromised individuals. Twelve cases of proven and
one case of probable invasive sinonasal dematiaceous fungal disease in immunocompromised patients
are reported in the English-language literature. The majority of patients had underlying hematological
conditions. The crude mortality was high, with over half of the patients dying from presumed
complications of the underlying immunosuppression. Successful outcomes were associated with
surgical debridement, aggressive antifungal use, and a reduction of immunosuppression. The optimal
treatment for immunocompromised patients with invasive dematiaceous fungal disease is not known.
The role of newer triazoles, posaconazole and voriconazole, appears promising, however more clinical
data are needed. Deﬁnitive diagnosis requires tissue biopsy and successful treatment is associated with
reduction of immunosuppression, aggressive surgical debulking, and systemic antifungal therapy.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Dematiaceous fungi are environmental pathogens, character-
ized by melanin in their cell wall.1,2 They are an uncommon yet
increasingly recognized source of invasive sinusitis.3–5 Although
destructive fungal sinus disease can occur in both immunocom-
petent and immunocompromised patients, disease in the latter is
of greater severity and acuity.3,4 Improved prognosis is associated
with surgical debridement, systemic antifungals,3–5 and an
effective host immune response.6,7 Although newer antifungals
are available, experience with triazoles such as posaconazole and
voriconazole, is limited. We report the ﬁrst case of invasive
dematiaceous fungal sinusitis in a pregnant woman with aplastic
anemia and provide a literature review of invasive dematiaceous
fungal sinonasal disease in immunocompromised hosts.
2. Case report
A 32-year-old Caucasian woman was diagnosed with aplastic
anemia and neutropenia during the second trimester of pregnancy.* Corresponding author. Tel.: +1 804 828 2121.
E-mail address: gbearman@mcvh-vcu.edu (G. Bearman).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.04.003Shewas admitted to our tertiary care center at gestational week 26
for a bonemarrow transplant evaluation. Upon admission, she had
a fever of 39.5 8C and a scabbing papule on her cheek. She was
treated with broad-spectrum antibiotics. Blood cultures and a skin
biopsy of the papule subsequently grew methicillin-susceptible
Staphylococcus aureus (MSSA).
Despite treatment of the MSSA bloodstream and soft tissue
infection, the high fever persisted and the patient reported nasal
congestion. A computed tomography (CT) scan revealed signiﬁcant
mucosal thickening of the left maxillary sinus with associated
hyperintense regions in the left frontal and bilateral sphenoid
sinus, and amucous retention cyst in the rightmaxillary sinus. A CT
scan of the chest revealed multiple, bilateral nodules with
surrounding ground glass consolidation. A serum galactomannan
antigen was negative. Broad-spectrum anti-infective coverage
with imipenem and liposomal amphotericin B was initiated. Three
days later she delivered a nonviable fetus.
After one week of antifungal therapy, a repeat CT scan of the
chest revealed progression of the bilateral ground glass consolida-
tion. A bronchoscopy and a video-assisted thorascopic lung biopsy
were performed. Cultures were nondiagnostic. Due to signiﬁcant
electrolyte abnormalities from liposomal amphotericin B (total
3000 mg), the antifungal therapy was changed to combination
posaconazole 200 mg by mouth four times a day and micafunginses. Published by Elsevier Ltd. All rights reserved.
C. Derber et al. / International Journal of Infectious Diseases 14S (2010) e329–e332e330100 mg intravenously daily. After 28 days, the imipenem was
discontinued and the patient was discharged home on posacona-
zole and micafungin.
One month later, the patient was readmitted with persistent
neutropenia, right facial pain and swelling. A repeat CT scan of the
sinuses revealed almost complete opaciﬁcation of the left
maxillary, left anterior, and left frontal sinuses. A CT scan of the
lungs revealed improved but persistent multifocal airspace
disease. The patient underwent a left maxillary antrostomy, left
anterior and posterior ethmoidectomies, and left middle turbinate
resection. Intra-operative ﬁndings included ulceration of the nasal
septum and necrotic mucosa of the left middle turbinate.
Histopathology was consistent with hyphal invasion of the
sinonasal respiratory mucosa. Exserohilum species was identiﬁed;
susceptibility testing was not performed.
The infectious diseases service subsequently expanded her
antifungal regimen to combination liposomal amphotericin B and
posaconazole. Three weeks later, a repeat sinus CT revealed
worsening of the left maxillary sinus opaciﬁcation. The patient
underwent additional sinus debridement. Pathology was again
consistent with a dematiaceous fungal infection. She developed
rigors on liposomal amphotericin B (total 14 000 mg) prompting a
change to micafungin 100 mg intravenously daily by the bone
marrow transplant service. The posaconazole was continued. One
month later, a CT scan revealed improvement in the sphenoid
sinuses and left frontal opaciﬁcation with ongoing disease in the
leftmaxillary sinus. Due to her refractory disease, the bonemarrow
transplant service changed the posaconazole to voriconazole
300 mg by mouth twice daily. She was subsequently discharged
home on micafungin and voriconazole.
Six weeks after the second sinus surgery, the patient was
readmitted with worsening headache, left facial pain and
unresolved neutropenia. A CT scan of the sinuses revealed ongoing
opaciﬁcation of the left maxillary sinus with bony irregularity of
the left maxillary sinus lateral wall and involvement of the inferior
wall of the left orbit. No intracranial invasion was noted. A CT scan
of the lungs revealed multiple areas of consolidation and nodular
opacities. The bone marrow transplant service initially added lipid
complex of amphotericin B (1800 mg total) to her prior regimen of
micafungin and voriconazole. She underwent a left maxillary
antrostomy and left sphenoidectomy. Pathology revealed tissue
invasion by fungal hyphae. Cultures were non-diagnostic. After
further consultation with the infectious diseases service, the
patient’s antifungal regimen was changed back to micafungin and
voriconazole.
Approximately six weeks after the third sinus surgery, the
patient was readmitted for further treatment of the aplastic
anemia. A CT scan revealed improvement in the right ethmoid, left
maxillary and sphenoid sinuses; increased inﬂammatory changes
in the left ethmoid sinuses; and no change in the right maxillary
sinus. Despite a trial of antithymocyte globulin and two months of
cyclosporine, the neutropenia persisted. She reported no addition-
al headaches or fevers. The patient was not a candidate for bone
marrow transplantation as adherence to her immunosuppressant
and antifungal regimenwas suboptimal. The patient ultimately left
the hospital with ongoing aplastic anemia and neutropenia. She
died approximately two months later from complications of the
underlying aplastic anemia. The status of her sinonasal disease at
the time of death was not known.
3. Literature review
A literature review of invasive sinonasal disease secondary to
dematiaceous fungi in immunocompromised individuals was
performed using the Medline/PubMed database. All searches were
limited to English-language articles. Immunocompromised hostswere deﬁned as those having neutropenia, a hematopoietic stem
cell transplant (HSCT), solid organ transplant, or cell-mediated
immunodeﬁciencies. The ﬁrst search term ‘phaeohyphomycosis
and invasive sinusitis’ yielded three articles, and a second search
term ‘dematiaceous fungi and invasive sinusitis’ yielded 16
articles. Additional searches under ‘invasive sinusitis’ or ‘nasal
septum’ and individual genera of dematiaceous fungi yielded 36
articles. Sinonasal disease due to Scedosporium species was not
included due to controversy regarding its classiﬁcation as a
dematiaceous fungus.1 Articles were reviewed to identify cases
with proven or probable sinonasal disease based on criteria
established by the European Organization for Research and
Treatment of Cancer/Invasive Fungal Infections Cooperative Group
and National Institute of Allergy and Infectious Diseases Mycoses
Study Group (EORTC/MSG) Consensus Group,8 and references from
these articles were reviewed to identify additional cases. Cases
with invasive nasal septum disease in the absence of concomitant
sinus disease were omitted. A total of 12 relevant articles, and
details on 13 immunocompromised patients with invasive
sinonasal disease, were found.9–20 An additional case of sinusitis
in a patient with aplastic anemia was omitted due to insufﬁcient
data available for classiﬁcation.21 All relevant articles were
published between 1987 and 2008.
4. Discussion
We report a unique case of acute invasive sinusitis due to
Exserohilum species in a pregnantwomanwith aplastic anemia and
prolonged neutropenia. Since 1987, there have been 14 (including
the present case) published cases of invasive sinonasal infection
due to dematiaceous fungi in immunocompromised individuals
(Table 1). In addition to the present case, 13 other cases were
biopsy ‘proven’ invasive sinonasal disease, although in three of
these cases the invasive pathology was cited in the skin11 or nasal
septum,15,20 rather than the sinuses. One case was considered
‘probable’ invasive sinonasal disease based on host and clinical
factors in the presence of sinusitis on imaging; however no tissue
or vessel invasion was described.13
Manifestations of both proven and probable invasive sinonasal
disease included disease localized to one or more sinuses or
sinonasal disease with dissemination. Twelve patients (86%),
including the present case, had underlying hematological condi-
tions.9–18 Three of these patients, including the present case, had
aplastic anemia.9,10 Six patients with invasive fungal sinusitis had
HSCTs,11–16 of whom four had infection diagnosed prior to the
transplant.11,12,14,16 Sinusitis was caused by Exserohilum species in
eight patients (including the present case),9–14 Alternaria species in
four patients,15,16,18,20 Curvularia species in one patient,17 and
Scytalidium species in one patient.19
The crude mortality in patients with invasive dematiaceous
fungal sinusitis is high, with over half of reported cases dying
during follow-up (9/14, 64%).9–11,13,14,17,19,20 Despite stabilization
or improvement in the invasive sinonasal disease, most died from
their underlying immunosuppression or other infec-
tions.10,11,13,14,17,19,20 Survival was associated in most cases with
resolution of neutropenia and immunosuppression. Most patients
who survived required a combination of surgical debridement and
systemic antifungal therapy. 12,15,18
Complications related to invasive dematiaceous fungal sinusitis
are common. Six patients, including the present case, had
associated pulmonary inﬁltrates.9,11,12,14,16 One patient with
disseminated Exserohilum disease had cutaneous involvement
manifesting as ecthyma gangrenosum.11 Another patient with
invasive Curvularia sinusitis had co-infection with Fusarium solani
in an orbital muscle abscess.17 Intracranial involvement compli-
cating destructive sinus disease from dematiaceous fungi has been
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not been reported in immunocompromised hosts.
Treatment of invasive sinonasal disease due to dematiaceous
fungi requires a combination of aggressive surgical debridement
and prolonged systemic antifungals. Historically, patients have
been treated with intravenous amphotericin B or oral itracona-
zole,3,5 however use of both may be limited by toxicity. Interest in
echinocandins and the newer triazoles, voriconazole and posaco-
nazole, has increased. In vitro testing with dematiaceous fungi
suggests variable activity for echinocandins and broad activity for
both voriconazole and posaconazole.1 Correlation between mini-
mum inhibitory concentrations and clinical outcomes for these
antifungals is lacking.1 Voriconazole was associated with a
successful treatment outcome in one patient with invasive
Exserohilum sinusitis and associated pulmonary disease.12 Three
deaths were reported in patients receiving voriconazole as part of
their antimicrobial regimen,10,17,19 however two of these patients
had no evidence of invasive fungal disease as the cause of
death.17,19 Another patient with invasive Alternaria sinusitis and
probable pulmonary disease recovered on posaconazole despite
recurrent disease with previous voriconazole use.16
The optimal duration of therapy of invasive sinonasal disease
due to dematiaceous fungi is not deﬁned; however neutrophil
recovery appears crucial for a successful outcome. In two HSCT
recipients with pre-existing invasive sinonasal mold infections,
antifungals were continued for approximately three months after
clinical resolution of the sinonasal disease12 or three months after
stopping all immunosuppressants.16 Both patients were restarted
on antifungals during periods of immunosuppression.12,16 The
treatment regimens for the other surviving patients were not
described as comprehensively in the published reports.
The association of pregnancy with progression or recurrence of
dematiaceous fungal disease has been described in immunocom-
petent women.26–29 Advanced fungal disease in pregnancy has
been attributed to impaired cell-mediated immunity, and may be
exacerbated by iron overload.30 Our patient had progressive fungal
disease during her pregnancy. Although pregnancy-related im-
paired cell-mediated immunity may have played a role in disease
onset, the aplastic anemia and persistent neutropenia were most
likely the principal disease contributors.
Our case adds to the body of literature on invasive fungal sinus
disease due to Exserohilum species. Our patient had histopathology
conﬁrmed sinonasal disease and probable fungal pulmonary
disease based on imaging studies, however the latter was not
conﬁrmed by tissue pathology or culture. Persistent radiographic
and histopathologic disease continued despite the use of systemic
antifungals for at least eight months. Her refractory disease was
likely multifactorial and related to poor adherence to therapy, her
impaired host immune status, and signiﬁcant burden of fungal
disease. In addition, antifungal susceptibilities were not obtained
on the initial sinus culture, so Exserohilum species antifungal non-
susceptibility cannot be excluded. Additional clinical experience is
necessary to better deﬁne optimal medical and surgical manage-
ment of invasive, sinonasal, dematiaceous fungal infections.
5. Conclusions
Acute invasive sinonasal disease due to dematiaceous fungi is
associated with immunosuppression and results in signiﬁcant
morbidity and mortality. Successful treatment requires reduction
of immunosuppression, aggressive surgical debridement, and
systemic antifungal therapy. Clinical experience with posacona-
zole and voriconazole is limited but promising. These agents may
have a role either in disease unresponsive to intravenous
amphotericin B or as ﬁrst-line agents. Further clinical experience
is needed to better deﬁne the use of these antifungal agents for the
C. Derber et al. / International Journal of Infectious Diseases 14S (2010) e329–e332e332management of invasive sinonasal disease secondary to dematiac-
eous fungi. In the setting of immunosuppression and pregnancy,
the presence of invasive fungal sinusitis should raise concern about
dematiaceous fungi and should trigger prompt antifungal therapy
and urgent surgical evaluation.
Conﬂict of interest:We received no funding from any sources for
this article. None of the authors has any commercial or proprietary
interest in any drug, device or equipmentmentioned in this article.
The authors declare no conﬂict of interest.
References
1. Revankar SG. Dematiaceous fungi. Mycoses 2007;50:91–101.
2. Revankar SG. Phaeohyphomycosis. Infect Dis Clin North Am 2006;20:609–20.
3. Chakrabarti A, Sharma SC. Paranasal sinus mycoses. Indian J Chest Dis Allied Sci
2000;42:293–304.
4. Washburn RG, Kennedy DW, Begley MG, Henderson DK, Bennett JE. Chronic
fungal sinusitis in apparently normal hosts.Medicine (Baltimore) 1988;67:231–
47.
5. Zieske LA, Kopke RD, Hamill R. Dematiaceous fungal sinusitis. Otolaryngol Head
Neck Surg 1991;105:567–77.
6. Douer D, Goldschmied-Reouven A, Segev S, Ben-Bassat I. Human Exserohilum
and Bipolaris infections: report of Exserohilum nasal infection in a neutropenic
patient with acute leukemia and review of the literature. J Med Vet Mycol
1987;25:235–41.
7. Ben-Ami R, Lewis RE, Raad II, Kontoyiannis DP. Phaeohyphomycosis in a tertiary
care cancer center. Clin Infect Dis 2009;48:1033–41.
8. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al.
Revised deﬁnitions of invasive fungal disease from the European Organization
for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative
Group and National Institute of Allergy and Infectious Diseases Mycoses Study
Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813–21.
9. Aquino VM, Norvell JM, Krisher K, Mustafa MM. Fatal disseminated infection
due to Exserohilum rostratum in a patient with aplastic anemia: case report and
review. Clin Infect Dis 1995;20:176–8.
10. La Sala PR, Smith MB, McGinnis MR, Sackey K, Patel JA, Qiu S. Invasive
Exserohilum sinusitis in a patient with aplastic anemia. Pediatr Infect Dis J
2005;24:939–41.
11. Levy I, Stein J, Ashenazi S. Ecthyma gangrenosum caused by disseminated
Exserohilum in a childwith leukemia: a case report and review of the literature.
Pediatr Dermatol 2003;20:495–7.
12. Adler A, Yaniv I, Samra Z, Yacobovich J, Fisher S, Avrahami G, et al. Exserohilum:
an emerging pathogen. Eur J Clin Microbiol Infect Dis 2006;25:247–53.
13. Togitani K, Kobayashi M, Sakai M, Uemura Y, Taguchi H, Morita T, et al.
Ethmoidal sinusitis caused by Exserohilum rostratum in a patient with malig-nant lymphoma after nonmyeloablative allogeneic peripheral blood stem cell
transplantation. Transpl Infect Dis 2007;9:137–41.
14. Avivi I, Oren I, Haddad N, Rowe JM, Dann EJ. Stem cell transplantation post
invasive fungal infection is a feasible task. Am J Hematol 2004;75:6–11.
15. Morrison VA, Welsdorf DJ. Alternaria: a sinonasal pathogen of immunocom-
promised hosts. Clin Infect Dis 1993;16:165–70.
16. Mullane K, Toor AA, Kalnicky C, Rodriguez T, Klein J, Stiff P. Posaconazole
salvage therapy allows successful allogeneic hematopoietic stem cell trans-
plantation in patientswith refractory invasivemold infections. Transpl Infect Dis
2007;9:89–96.
17. Peden MC, Neelakantan A, Orlando C, Khan SA, Lessner A, Bhatti MT. Breaking
the mold of orbital cellulitis. Surv Opthalmol 2008;53:631–5.
18. Iwen PC, Rupp ME, Hinrichs SH. Invasive mold sinusitis: 17 cases in immuno-
compromised patients and review of the literature. Clin Infect Dis 1997;
24:1178–84.
19. Dunn JJ, Wolfe MJ, Trachtenberg J, Kriesel JD, Orlandi RR, Carroll KC. Invasive
fungal sinusitis caused by Scytalidium dimidiatum in a lung transplant patient. J
Clin Microbiol 2003;41:5817–9.
20. Wiest PM,Wiese K, JacobsMR,Morrisey AB, Abelson TI. Alternaria infection in a
patient with acquired immunodeﬁciency syndrome: case report and review of
invasive Alternaria infection. Rev Infect Dis 1987;9:799–803.
21. Sharkey PK, Graybill JR, Rinaldi MG, Stevens DA, Tucker RM, Peterie JD, et al.
Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 1990;
23:577–86.
22. Brown JW, Nadell J, Sanders CV, Sardenga L. Brain abscess caused by Clados-
porium trichoides (Bantianum): a case with paranasal sinus involvement. South
Med J 1976;69:1519–21.
23. McGinnis MR, Campbell G, Gourley WK, Lucia HL. Phaeohyphomycosis
caused by Bipolaris spicifera: an informative case. Eur J Epidemiol 1992;
8:383–6.
24. Aviv JE, Lawson W, Bottone EJ, Sachdev VP, Som PM, Biller HF. Multiple
intracranial mucoceles associated with phaeohyphomycosis of the paranasal
sinuses. Arch Otolaryngol Head Neck Surg 1990;116:1210–4.
25. Saberi H, Kashﬁ A, Hamidl S, Tabatabal SAF, Mansouri P. Cerebral phaeohy-
phomycosis masquerading as a parafalcian mass: case report. Surg Neurol
2003;60:254–9.
26. Negroni R, Helou SH, Petri N, Robles AM, Arechavala A, Bianchi MH. Case study:
posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala
spinifera. Clin Infect Dis 2004;38:e15–20.
27. Proia LA, Trenholme GM. Chronic refractory phaeohyphomycosis: successful
treatment with posaconazole. Mycoses 2006;49:519–22.
28. Pratt MF, Burnett JR. Fulminant Drechslera sinusitis in an immunocompetent
host. Laryngoscope 1988;97:1343–7.
29. Fletcher H, Williams NP, Nicholson A, Rainford L, Phillip H, East-Innis A.
Systemic phaeohyphomycosis in pregnancy and the puerperium. West Indian
Med J 2000;49:79–82.
30. Weinberg ED. Pregnancy-associated depression of cell-mediated immunity. Rev
Infect Dis 1984;6:814–31.
